Stock listing
NASDAQ:RLYP Relypsa Inc Stock
Follow Relypsa Inc into a list and get an email when it puts out news.
Last close · NASDAQ:RLYP
$31.99 USD
Close on Aug 31, 2016 · No longer trades
- Lowest – highest close
- $11.76 – $46.05 USDSince Nov 15, 2013 · lowest Oct 22, 2015 · highest Mar 18, 2014
Delisted NASDAQ:RLYP no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:RLYP
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| David McGirr Other companies: X4 Pharmaceuticals, Inc. (Director · Since at least Nov 15, 2017); Rhythm Pharmaceuticals, Inc. (Director · Since at least Oct 4, 2017); Insmed Incorporated (Director · Since at least Oct 30, 2013); Roka Bioscience Inc (Director · Jul 16, 2014 – Jun 28, 2017 · Past); Cubist Pharmaceuticals Inc (SVP & Chief Financial Officer · Mar 31, 2010 – Feb 15, 2013 · Past) | Director · Nov 14, 2013 – Sep 1, 2016 · Past |
| Thomas J. Schuetz Other companies: Compass Therapeutics, Inc. (Chief Executive Officer, Compass Therapeutics · Since at least Jun 17, 2020); Audentes Therapeutics Inc (Director · Jul 19, 2016 – Jan 15, 2020 · Past) | Director · Nov 14, 2013 – Sep 1, 2016 · Past |
| Mary Corbett | Senior VP, Human Resources · Jun 3, 2016 – Sep 1, 2016 · Past |
| Monte Montgomery | Chief Accounting Officer · Aug 1, 2016 – Sep 1, 2016 · Past |
Log in to ask 6ix AI your own questions about Relypsa Inc.